Skip to content

Polypeptide N-acetylgalactosaminyltransferase 15 (GALNT15)

Homo sapiens — UniProt Q8N3T1

Gene: GALNT15Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Polypeptide N-acetylgalactosaminyltransferase 15 (GALNT15) is a protein from Homo sapiens identified by UniProt accession Q8N3T1, 639 residues long. MolForge cross-references it against 0 known binders and 29 disease associations.

  • UniProt accession: Q8N3T1; gene symbol GALNT15.
  • Organism: Homo sapiens.
  • Length: 639 amino acids.
  • Top disease associations (Open Targets): diffuse plaque measurement, protein measurement and refractive error.
  • 3D structure: AlphaFold model available.

Target properties

Protein namePolypeptide N-acetylgalactosaminyltransferase 15
UniProt accessionQ8N3T1
GeneGALNT15
OrganismHomo sapiens
Length639 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (29)

Diseases linked to this target (Open Targets).

  • diffuse plaque measurement · score 0.30
  • protein measurement · score 0.29
  • refractive error · score 0.06
  • age at onset · score 0.05
  • Myopia · score 0.05
  • Abnormality of refraction · score 0.05
  • Crohn's disease · score 0.02
  • hepatocellular carcinoma · score 0.02
  • esophageal squamous cell carcinoma · score 0.01
  • myxosarcoma · score 0.01

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8N3T1-F1alphafoldPREDICTED78.18—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8N3T1.

Amino-acid sequence (639 residues)

MLLRKRYRHR PCRLQFLLLL LMLGCVLMMV AMLHPPHHTL HQTVTAQASK HSPEARYRLD FGESQDWVLE AEDEGEEYSP LEGLPPFISL REDQLLVAVA LPQARRNQSQ GRRGGSYRLI KQPRRQDKEA PKRDWGADED GEVSEEEELT PFSLDPRGLQ EALSARIPLQ RALPEVRHPL CLQQHPQDSL PTASVILCFH DEAWSTLLRT VHSILDTVPR AFLKEIILVD DLSQQGQLKS ALSEYVARLE GVKLLRSNKR LGAIRARMLG ATRATGDVLV FMDAHCECHP GWLEPLLSRI AGDRSRVVSP VIDVIDWKTF QYYPSKDLQR GVLDWKLDFH WEPLPEHVRK ALQSPISPIR SPVVPGEVVA MDRHYFQNTG AYDSLMSLRG GENLELSFKA WLCGGSVEIL PCSRVGHIYQ NQDSHSPLDQ EATLRNRVRI AETWLGSFKE TFYKHSPEAF SLSKAEKPDC MERLQLQRRL GCRTFHWFLA NVYPELYPSE PRPSFSGKLH NTGLGLCADC QAEGDILGCP MVLAPCSDSR QQQYLQHTSR KEIHFGSPQH LCFAVRQEQV ILQNCTEEGL AIHQQHWDFQ ENGMIVHILS GKCMEAVVQE NNKDLYLRPC DGKARQQWRF DQINAVDER

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with GALNT15?

The strongest Open Targets associations for GALNT15 are diffuse plaque measurement, protein measurement, refractive error, age at onset and Myopia.

How long is the GALNT15 protein?

The Homo sapiens GALNT15 protein (UniProt Q8N3T1) is 639 amino acids long.

Browse: Targets: G · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Polypeptide N-acetylgalactosaminyltransferase 15 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8N3T1
GeneGALNT15
OrganismHomo sapiens
Length639
Binders0
Diseases29
View on UniProt